Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel disease
暂无分享,去创建一个
D. Haller | M. Blaut | G. Duncan | S. Wohlgemuth | E. Collie-Duguid | C. Reiff | M. Delday | G. Rucklidge | M. Reid | G. Hoermannsperger | G. Loh | E. Collie-Duguid | D. Kelly | G. Hörmannsperger | Garry J. Rucklidge | Dirk Haller | Martin D. Reid | Gary Duncan | Steffen Wohlgemuth | Gunnar Loh | Michael Blaut | Denise Kelly